Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study
Crossref DOI link: https://doi.org/10.1186/s12891-016-1289-z
Published Online: 2016-10-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Voshaar, Marieke
Vriezekolk, Johanna
van Dulmen, Sandra
van den Bemt, Bart
van de Laar, Mart
Funding for this research was provided by:
Roche (Unrestricted Grant)
License valid from 2016-10-21